Showing results (41-50 of 253) with videos related to
Sort By:
Pageof 26
Blood|October 25, 2019
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapyAlexandre V Hirayama, Jordan Gauthier, Kevin A Hay, et al.Expert Review of Hematology|October 23, 2024
Evolving strategies to overcome barriers in CAR-T cell therapy for acute myeloid leukemiaChanukya K Colonne, Erik L Kimble, Cameron J TurtleThe Journal of Experimental Medicine|May 14, 2003
A human minor histocompatibility antigen resulting from differential expression due to a gene deletionMakoto Murata, Edus H Warren, Stanley R RiddellBlood Advances|November 4, 2022
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapyAlexandre V Hirayama, Cassie K Chou, Takahiro Miyazaki, et al.Science Translational Medicine|September 9, 2016
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cellsCameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, et al.Science Translational Medicine|March 27, 2015
Adoptive cellular therapy: a race to the finish lineCarl H June, Stanley R Riddell, Ton N SchumacherBlood|May 6, 2018
Chimeric antigen receptor-modified T cells: CD19 and the road beyondAlexander I Salter, Margot J Pont, Stanley R RiddellExpert Opinion on Biological Therapy|August 21, 2007
Genetic modification of T cells for immunotherapyCarolina Berger, Michael Berger, Junli Feng, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell TransplantationAbir Bhattacharyya, Laïla-Aïcha Hanafi, Alyssa Sheih, et al.Nature Reviews. Clinical Oncology|February 18, 2025
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphomaTamara J Bock, Chanukya K Colonne, Salvatore Fiorenza, et al.Pageof 26